Approval · Notice of Compliance 414 · 2002
MINIRIN: Notice of Compliance 414
Issued October 17, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 414
- Date
- October 17, 2002
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antidiuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINIRIN | 02246500 | Cancelled Post Market |
| MINIRIN | 02246505 | — |
Medicinal ingredients
- DESMOPRESSIN ACETATE 0.1 MG per TAB
- DESMOPRESSIN ACETATE 0.2 MG per TAB